Tag: growth-and

Natural extract shows promise for preventing breast cancer, study suggests

| March 29, 2015 | 0 Comments

In a new study, the extract from rosehips — the fruit of the rose plant — significantly reduced the growth and migration of cells from a type of breast cancer known as triple negative. This particularly aggressive form of cancer does not respond to most available treatments and tends to affect young women as well as those who are African-American or Hispanic.

Continue Reading

Natural Extract Shows Promise for Preventing Breast Cancer

| March 29, 2015 | 0 Comments

In a new study, the extract from rosehips — the fruit of the rose plant — significantly reduced the growth and migration of cells from a type of breast cancer known as triple negative. This particularly aggressive form of cancer does not respond to most available treatments and tends to affect young women as well as those who are African-American or Hispanic.

Continue Reading

Clinical trial for solid tumors with novel small molecule agent

| March 4, 2015 | 0 Comments

Rutgers Cancer Institute of New Jersey is offering a clinical trial examining the investigational treatment known as ONC201 in patients with solid tumors whose cancer no longer responds to standard therapy. Prior research on the study drug suggests that it may be capable of turning off proteins that maintain tumor growth and and may help kill cancer cells while sparing normal ones.

Continue Reading

Rutgers Cancer Institute of New Jersey Offers Clinical Trial for Solid Tumors with Novel Small Molecule Agent

| March 4, 2015 | 0 Comments

Rutgers Cancer Institute of New Jersey is offering a clinical trial examining the investigational treatment known as ONC201 in patients with solid tumors whose cancer no longer responds to standard therapy. Prior research on the study drug suggests that it may be capable of turning off proteins that maintain tumor growth and and may help kill cancer cells while sparing normal ones.

Continue Reading

Research findings may lead to new treatment strategies for Ewing sarcoma

| December 18, 2014 | 0 Comments

The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes – both activating genes that stimulate tumor growth and suppressing those that should keep cancer from developing. These findings by Massachusetts General Hospital investigators, published in the November issue of Cancer Cell, may lead to new therapies targeting these aberrant mechanisms.

Continue Reading

Cancer-Linked Colgate Total Ingredient Suggests Flaws in FDA Approval Process

| August 11, 2014 | 0 Comments

The chemical triclosan has been linked to cancer-cell growth and disrupted development in animals. At the same time, millions of Americans are putting it in their mouths every day, by way of a top-selling toothpaste that uses the antibacterial chemical to head off gum disease — Colgate-Palmolive Co.’s Total. Total is safe, Colgate says, citing the rigorous Food and Drug Administration process …

Continue Reading

MEI Pharma Identifies Potential Biomarker For Pracinostat In Bladder Cancer

| April 7, 2014 | 0 Comments

SAN DIEGO, April 7, 2014 /PRNewswire/ — MEI Pharma, Inc.

Continue Reading

Researchers slow pancreatic cancer growth by blocking key enzyme

| March 12, 2014 | 0 Comments

( Pancreatic Cancer Research Fund ) A research team from Imperial College London has shown that blocking the function of an enzyme known as Hhat slows the growth and spread of pancreatic cancer, by preventing a protein called Hedgehog from stimulating nearby normal cells to help the cancer.

Continue Reading

Cancer stem cells killed by trial drug

| January 19, 2014 | 0 Comments

BRITISH scientists have discovered a “breakthrough” new treatment that kills virulent cancer stem cells suspected of driving tumour growth and causing recurring disease.

Continue Reading

Advanced-stage ovarian cancer treated with targeted nanomedicine

| December 10, 2013 | 0 Comments

Researchers at Rutgers, the State University of New Jersey, have used a targeted nanomedicine approach to deliver small molecule drugs and successfully treat mice with deadly advanced-stage ovarian cancer.Writing about their work in a recent print issue of the journal Clinical Cancer Research, the team explains how an out-of-control protein called CD44 aids tumor growth and development of drug …

Continue Reading